Haploinsufficiency as a disease mechanism in GNB1‐associated neurodevelopmental disorder. Issue 11 (12th September 2020)

• Record Type: Journal Article
• Authors: Schultz‐Rogers, Laura; Masuho, Ikuo; Pinto e Vairo, Filippo; Schmitz, Christopher T.; Schwab, Tanya L.; Clark, Karl J.; Gunderson, Lauren; Pichurin, Pavel N.; Wierenga, Klaas; Martemyanov, Kirill A.; Klee, Eric W.
• Is Part Of: Molecular genetics & genomic medicine. Volume 8:Issue 11(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-09-12
• Subjects: Medical genetics -- Periodicals; Genomics -- Periodicals; 616.042
• DOI: 10.1002/mgg3.1477
• Languages: English
• ISSNs: 2324-9269

Abstract

Abstract: Background: GNB1 encodes a subunit of a heterotrimeric G‐protein complex that transduces intracellular signaling cascades. Disruptions to the gene have previously been shown to be embryonic lethal in knockout mice and to cause complex neurodevelopmental disorders in humans. To date, the majority of variants associated with disease in humans have been missense variants in exons 5‐7. Methods: Genetic sequencing was performed on two patients presenting with complex neurological phenotypes including intellectual disability, hypotonia, and in one patient seizures. Reported variants were assessed using RNA sequencing and functional BRET/BiFC assays. Results: A splice variant reported in patient 1 was confirmed to cause usage of a cryptic splice site leading to a truncated protein product. Patient 2 was reported to have a truncating variant. BRET and BiFC assays of both patient variants confirmed both were deficient in inducing GPCR‐induced G protein activation due to lack of dimer formation with the Gγ subunit. Conclusion: Here, we report two patients with functionally confirmed loss of function variants in GNB1 and neurodevelopmental phenotypes including intellectual disability, hypotonia, and seizures in one patient. These results suggest haploinsufficiency of GNB1 is a mechanism for neurodevelopmental disorders in humans. Abstract : Missense variants in GNB1 are associated with a complex neurodevelopmental disorder. Here we present two additional patients with overlapping phenotypes including developmental delay, hypotonia, intellectual disability, and seizures in one patient. Both patients have presumed loss‐of‐function variants which we have shown functionally to cause loss of protein function, thus adding evidence that haploinsufficiency is a disease mechanism associated with GNB1.